Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy

被引:31
作者
Mutlak, Michael [1 ,2 ]
Schlesinger-Laufer, Michal [3 ]
Haas, Tali [3 ]
Shofti, Rona [3 ]
Ballan, Nimer [1 ,2 ]
Lewis, Yair E. [1 ,2 ]
Zuler, Mor [1 ,2 ]
Zohar, Yaniv [4 ]
Caspi, Lilac H. [1 ,2 ]
Kehat, Izhak [1 ,2 ,5 ,6 ]
机构
[1] Technion Israel Inst Technol, Rappaport Inst, Efron St 6,POB 9649, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Efron St 6,POB 9649, IL-31096 Haifa, Israel
[3] Technion Israel Inst Technol, Preclin Res Author Unit, Haifa, Israel
[4] Rambam Med Ctr, Dept Pathol, IL-31096 Haifa, Israel
[5] Rambam Med Ctr, Dept Cardiol, IL-31096 Haifa, Israel
[6] Rambam Med Ctr, Clin Res Inst Rambam, IL-31096 Haifa, Israel
基金
以色列科学基金会;
关键词
Extracellular signal-regulated kinase (ERK); Cardiac hypertrophy; Mitogen-activated protein kinases (MAPKs); Contractile function; LEFT-VENTRICULAR MASS; TRANSCRIPTION FACTOR GATA4; GOOD THERAPEUTIC STRATEGY; HEART-FAILURE; PROTEIN-KINASE; IN-VIVO; PHOSPHORYLATION; PATHWAYS; TARGETS; LOOP;
D O I
10.1016/j.ijcard.2018.05.068
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chronic pressure overload and a variety of mediators induce concentric cardiac hypertrophy. When prolonged, cardiac hypertrophy culminates in decreasedmyocardial function and heart failure. Activation of the extracellular signal-regulated kinase (ERK) is consistently observed in animal models of hypertrophy and in human patients, but its role in the process is controversial. Methods: We generated transgenicmouse lines with cardiomyocyte restricted overexpression of intrinsically active ERK1, which similar to the observations in hypertrophy is phosphorylated on both the TEY and the Thr207 motifs and is overexpressed at pathophysiological levels. Results: The activated ERK1 transgenic mice developed amodest adaptive hypertrophywith increased contractile function and without fibrosis. Following induction of pressure-overload, where multiple pathways are stimulated, this activation did not further increase the degree of hypertrophy but protected the heart through a decrease in the degree of fibrosis and maintenance of ventricular contractile function. Conclusions: The ERK pathway acts to promote a compensated hypertrophic response, with enhanced contractile function and reduced fibrosis. The activation of this pathway may be a therapeutic strategy to preserve contractile function when the pressure overload cannot be easily alleviated. The inhibition of this pathway, which is increasingly being used for cancer therapy on the other hand, should be used with caution in the presence of pressure-overload. (c) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:204 / 213
页数:10
相关论文
共 48 条
[31]   Differences between pathological and physiological cardiac hypertrophy: Novel therapeutic strategies to treat heart failure [J].
McMullen, Julie R. ;
Jennings, Garry L. .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (04) :255-262
[32]   Phosphorylation or Mutation of the ERK2 Activation Loop Alters Oligonucleotide Binding [J].
McReznolds, Andrea C. ;
Karra, Aroon S. ;
Li, Yan ;
Daniel Lopez, Elias ;
Turjanski, Adrian G. ;
Dioum, Elhadji ;
Lorenz, Kristina ;
Zaganjor, Elma ;
Stippec, Steve ;
McGlynn, Kathleen ;
Earnest, Svetlana ;
Cobb, Melanie H. .
BIOCHEMISTRY, 2016, 55 (12) :1909-1917
[33]   Extracellular signal-regulated kinases 1/2 as regulators of cardiac hypertrophy [J].
Mutlak, Michael ;
Kehat, Izhak .
FRONTIERS IN PHARMACOLOGY, 2015, 6
[34]   Controversies in Cardiology 4 - Controversies in ventricular remodelling [J].
Opie, LH ;
Commerford, PJ ;
Gersh, BJ ;
Pfeffer, MA .
LANCET, 2006, 367 (9507) :356-367
[35]   Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale [J].
Rose, Beth A. ;
Force, Thomas ;
Wang, Yibin .
PHYSIOLOGICAL REVIEWS, 2010, 90 (04) :1507-1546
[36]   Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy [J].
Ruppert, Catharina ;
Deiss, Katharina ;
Herrmann, Sebastian ;
Vidal, Marie ;
Oezkur, Mehmet ;
Gorski, Armin ;
Weidemann, Frank ;
Lohse, Martin J. ;
Lorenz, Kristina .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (18) :7440-7445
[37]   Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy [J].
Sakamoto, Masaya ;
Minamino, Tohru ;
Toko, Haruhiro ;
Kayama, Yosuke ;
Zou, Yunzeng ;
sano, Mari Sano ;
Takaki, Eiichi ;
Aoyagi, Teruhiko ;
Tojo, Katsuyoshi ;
Tajima, Naoko ;
Nakai, Akira ;
Aburatani, Hiroyuki ;
Komuro, Issei .
CIRCULATION RESEARCH, 2006, 99 (12) :1411-1418
[38]   Is Inhibition of Hypertrophy a Good Therapeutic Strategy in Ventricular Pressure Overload? [J].
Schiattarella, Gabriele G. ;
Hill, Joseph A. .
CIRCULATION, 2015, 131 (16) :1435-1447
[39]   Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence [J].
Selvetella, G ;
Hirsch, E ;
Notte, A ;
Tarone, G ;
Lembo, G .
CARDIOVASCULAR RESEARCH, 2004, 63 (03) :373-380
[40]   The MEK/ERK cascade: From signaling specificity to diverse functions [J].
Shaul, Yoav D. ;
Seger, Rony .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (08) :1213-1226